Digital Therapeutics

Sponsored by: GlobalData

Focused on:

    Date: 17 June

    Days to go: 1

    Time: 3PM London/10AM New York

    Impact on healthcare

    Due to increasing levels of healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent a new approach to treatment in which digital systems are used as regulatory-approved, prescribed therapeutic interventions. There is a growing number of DTx on the market today as well as pipeline products in development following the establishment of internationally-recognized, quality, design and manufacturing standards. DTx are expected to provide a new approach to disease management in which patients have the ability to learn more about their conditions and treatment options, thereby enabling better health and disease management. Despite these technologies having the potential to reduce total healthcare costs, improve trial outcomes and patients' health, there are few challenges to address before they become an integral part of modern medicine. For example, providers, payers, and manufacturers must achieve alignment on how to support the adoption of DTx in clinical practice.

    In this webinar, GlobalData's Senior Healthcare Analyst, Alessio Brunello, MSc, will provide an overview of the key DTx available in the market and in the pipeline. The webinar will cover the current attitude of the healthcare industry towards DTx, the challenges and opportunities surrounding the adoption of DTx, and key requirements for success.

    Dr. Valentina Gburcik, GlobalData's Senior Director, will moderate a Q&A session following the presentation. Join this webinar to increase your knowledge of the current outlook for DTx in healthcare

    Presented by

    Alessio Brunello,

    Senior Analyst ā€“ Neurology and Ophthalmology

    Alessio Brunello, MSc, is a Senior Analyst of Neurology and Ophthalmology at GlobalData in London. He provides in-depth scientific analysis of products within the neurology pharmaceutical sector, and constructs market forecast models based on business intelligence. Prior to working at GlobalData, Alessio worked as a researcher at Policlinico Gemelli in Rome, Italy as part of a clinical study in Orthopaedics. He also completed a summer internship for a consulting firm in London, where he developed a pricing and market access strategy for a novel drug. Alessio holds an MSc in International Health Management from Imperial College London where he gained extensive experience in management and business in the Healthcare sector.

    Valentina Gburcik,

    Senior Director ā€“ CVMD, Gender Health and Digital

    Valentina Gburcik, PhD, is a Senior Director at GlobalData where she oversees the production of syndicated reports and drug forecasts across a range of high-profile and niche therapeutic indications. She also manages the digital team in the production of digital landscape reports and webinars across various indications. Prior to joining GlobalData more than six years ago, Valentina was an academic researcher and a co-founder of a spin-off company at the Royal Veterinary College, London. She also worked as a postdoctoral researcher at University College London and as a project manager at a biotech company Imuthes. Valentina holds a PhD from the University of Geneva and a Certificate in Entrepreneurship from the CTI, Swiss federal training programme. She also holds a BSc degree in Biochemistry from the University of Belgrade.

    Key Learning Objectives

    • Learn key attributes and definitions of DTx
    • Gain insight of some marketed and pipeline DTx in healthcare
    • Learn how DTx will impact on healthcare
    • Identify the challenges and opportunities to implementing DTx


    • Managers/Senior Managers/Associate Directors/Directors of Market Research
    • Business Insights
    • Market Intelligence
    • Strategic Insights
    • Forecasting
    • Competitive Strategy
    • Customer Insights
    • Heads of Research and Development
    • Heads of Product Planning and Marketing
    • Brand Managers
    • Market Access
    • Health Economics and Outcomes Research
    • Pharmaceutical Pricing
    • Pharmaceutical Licensing
    • Government and Public Affairs
    • Drug Development
    • Regulatory Affairs
    • Medical Affairs
    • Market Access Consultant